Physician Assistant, Medical · Glen Burnie, MD
NPI
1942606462
Since 2014
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
7704 Quarterfield Rd Ste E
Glen Burnie, MD, 21061
Phone (855) 527-7246
Groups this clinician bills Medicare through
Medicare paid, 2024
$354K
22,411 services
Medicare patients, 2024
320
Average age 68
Drug cost, 2024
$548K
6,895 prescriptions
Company payments, 2025
$1,947
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sara Makrinos was code J7328 (hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg), 8,064 times for 14 patients. In total Sara Makrinos billed 22,411 services in 24 codes, and Medicare paid $354K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-06-17.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J7328 Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | Office | 8,064 | 14 | $0.38 | $3,089 |
| 99214 Office E&M - Established | Office | 2,291 | 301 | $85.08 | $195K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 2,240 | 36 | $0.10 | $225 |
| J7332 Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg | Office | 920 | 13 | $8.14 | $7,493 |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 454 | 230 | $153.46 | $70K |
| 80307 Drug Tests | Office | 436 | 217 | $60.79 | $27K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 339 | 23 | $0.09 | $30.03 |
| 20611 Joint Injection | Office | 155 | 63 | $74.00 | $11K |
| 99213 Office E&M - Established | Office | 59 | 43 | $61.28 | $3,616 |
| 20552 Musculoskeletal | Office | 49 | 23 | $36.57 | $1,792 |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 23 | 20 | $194.77 | $4,480 |
| J1030 Injection, methylprednisolone acetate, 40 mg | Office | 11 | 11 | $4.58 | $50.4 |
By year: 2022 $387K for 19,469 services; 2023 $410K for 30,869 services; 2024 $354K for 22,411 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 454 | 230 | $153.46 | $70K |
| 80307 Drug Tests | 436 | 217 | $60.79 | $27K |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 23 | 20 | $194.77 | $4,480 |
Medicare prescription drug claims, 2024
In 2024, the drug Sara Makrinos prescribed most often to Medicare patients was Oxycodone Hcl, with 1,321 prescriptions and refills. In total Sara Makrinos wrote 6,895 Medicare prescriptions that cost $548K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 1,321 | 1,323 | 183 | $24K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 868 | 868 | 123 | $22K |
| Gabapentin Generic | 643 | 864 | 117 | $12K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 535 | 535 | 78 | $11K |
| Morphine Sulfate Er Morphine Sulfate | 388 | 389 | 58 | $6,273 |
| Tizanidine Hcl Generic | 300 | 378 | 54 | $2,575 |
| Pregabalin Generic | 293 | 329 | 47 | $6,729 |
| Cyclobenzaprine Hcl Generic | 281 | 301 | 64 | $3,119 |
| Tramadol Hcl Generic | 173 | 173 | 34 | $1,720 |
| Baclofen Generic | 121 | 138 | 27 | $1,755 |
| Methocarbamol Generic | 111 | 121 | 31 | $1,192 |
| Diclofenac Sodium Generic | 109 | 131 | 29 | $3,660 |
| Meloxicam Generic | 104 | 138 | 24 | $327 |
| Morphine Sulfate Generic | 101 | 101 | 17 | $2,338 |
| Oxycontin Oxycodone Hcl | 92 | 93 | 13 | $38K |
Brand drugs: 658 claims; generic drugs: 6,237 claims; opioid claims: 3,904.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sara Makrinos $1,947 ($1,947 in general payments such as food, travel and fees) from 16 companies. The largest payer was Abbvie Inc. with $342.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 24 | $342 |
| Boston Scientific Corporation BSX | 19 | $326 |
| Collegium Pharmaceutical, Inc. COLL | 21 | $274 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 14 | $253 |
| Lundbeck LLC | 6 | $136 |
| Pfizer Inc. PFE | 4 | $124 |
| Averitas Pharma Inc. | 5 | $117 |
| Amgen Inc. AMGN | 4 | $78.92 |
| Abbott Laboratories ABT | 3 | $58.39 |
| Tonix Medicines, Inc. | 2 | $54.54 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.